Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer

Fig. 6

Morphometrical analysis of the treated (Cetuximab, Pembrolizumab and Oxaliplatin) and untreated (control) tissue slices. Stacked plots show the medians of the areas of necrosis (blue), stroma (orange) and tumor (grey) normalized to the total area analyzed. Statistical differences between the groups were calculated using the Mann-Whitney U test and marked with a parenthesis and a label (p ≤ 0.05). 1- control; 2- Oxaliplatin 20 μM; 3- Oxaliplatin 5 μM; 4- Cetuximab 200 nM; 5- Cetuximab 20 nM; 6- Pembrolizumab 1400 nM; 7- Pembrolizumab 140 nM

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us